药物开发 药物开发
Alan Kott1, Xingmei Wang2, David S Miller2
1Signant Health, Prague, Czech Republic.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
在临床试验的早期确定患有严重阿尔茨海默氏症 (AD) 症状的受试者至关重要. 三个关键因素显著增加了参与者过于严重的早期AD试验的可能性.
科学领域:
- 神经科学是一个神经科学.
- 临床试验 临床试验
- 老年学是指老年学的学科.
背景情况:
- 以前的分析表明,早期阿尔茨海默病 (AD) 试验中高比例的受试者超过了协议严重性要求.
- 确定了个人因素,以帮助在查期间识别过度严重的受试者.
研究的目的:
- 评估已识别的风险因素的预测性能,单独和组合,在查时区分过度严重的受试者.
- 为了提高早期AD临床试验对象选择的准确性.
主要方法:
- 查和基线数据的后勤回归分析,来自早期AD试验中的1966名受试者.
- 测试了三种分类风险因素的组合:查迷你精神状态检查 (MMSE) 面试时间,MMSE得分和确认性认知测试的表现.
主要成果:
- 三种风险因素中的任何一种存在,都会显著增加受试者比协议要求更严重的几率.
- 一个风险因素增加了两到八倍的几率,两个因素增加了7到13倍,所有三个因素增加了22倍.
结论:
- 查MMSE得分接近值,更长的MMSE访谈时间和认知测试表现差的组合确定受试者超过基线严重性标准的可能性是22倍.
- 这种预测模型可以帮助研究人员在随机化之前选不合格的受试者,从而保持临床试验的完整性.
- 限制包括追溯性质和专注于MMSE数据.
更多相关视频
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
3.3K
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
451
相关概念视频
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation
279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
